Tiny implant in lung arteries could give heart failure patients a new lease on life

NCT ID NCT05230745

Recruiting now Disease control Sponsor: Restore Medical Ltd Source: ClinicalTrials.gov ↗

First seen Feb 05, 2026 · Last updated May 20, 2026 · Updated 20 times

Summary

This study tests a device called ContraBand™ that is placed in the lung arteries to reduce pressure on the heart. It aims to improve heart function and exercise ability in people with chronic left-sided heart failure. About 55 adults aged 18–85 with moderate to severe symptoms will take part. The study checks if the device is safe and works as intended.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Site
RECRUITING

Aalst, Belgium
Clinical Site
RECRUITING

Antwerp, Belgium
Clinical Site
RECRUITING

Genk, Belgium
Clinical Site
RECRUITING

Lübeck, Germany
Clinical Site
RECRUITING

Nahariya, Israel
Clinical Site
RECRUITING

Petah Tikva, Israel
Clinical Site
RECRUITING

Klaipėda, Lithuania
Clinical Site
RECRUITING

Krakow, Poland
Clinical Site
RECRUITING

Lublin, Poland
Kaplan Medical Center
RECRUITING

Rehovot, Israel
Tbilisi Heart and Vascular Clinic
RECRUITING

Tbilisi, Georgia
Vilnius University Hospital Santaros Klinikos
RECRUITING

Vilnius, Lithuania

Conditions

Explore the condition pages connected to this study.

HEART FAILURE, LEFT SIDED